Schonfeld Strategic Advisors’s TELA Bio TELA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-12,200
Closed -$30.9K 2377
2024
Q3
$30.9K Sell
12,200
-20,890
-63% -$74.3K ﹤0.01% 1908
2024
Q2
$156K Sell
33,090
-1,910
-5% -$10.1K ﹤0.01% 1843
2024
Q1
$198K Sell
35,000
-19,600
-36% -$129K ﹤0.01% 1774
2023
Q4
$361K Sell
54,600
-16,700
-23% -$96.5K ﹤0.01% 1375
2023
Q3
$570K Sell
71,300
-111,000
-61% -$1.03M ﹤0.01% 1174
2023
Q2
$1.85M Sell
182,300
-32,749
-15% -$335K 0.02% 775
2023
Q1
$2.29M Buy
215,049
+20,826
+11% +$230K 0.02% 654
2022
Q4
$2.23M Buy
194,223
+35,400
+22% +$317K 0.02% 779
2022
Q3
$1.35M Buy
158,823
+18,451
+13% +$153K 0.01% 1085
2022
Q2
$984K Sell
140,372
-5,364
-4% -$44.5K 0.01% 1038
2022
Q1
$1.69M Buy
145,736
+1,600
+1% +$19.4K 0.02% 794
2021
Q4
$1.84M Sell
144,136
-217
-0.2% -$2.75K 0.02% 730
2021
Q3
$1.97M Buy
144,353
+7,400
+5% +$103K 0.02% 720
2021
Q2
$2.21M Buy
136,953
+17,467
+15% +$239K 0.02% 679
2021
Q1
$1.78M Sell
119,486
-10,363
-8% -$156K 0.02% 703
2020
Q4
$1.95M Sell
129,849
-4,900
-4% -$79.5K 0.03% 605
2020
Q3
$2.23M Sell
134,749
-21,089
-14% -$296K 0.04% 480
2020
Q2
$2.02M Buy
155,838
+123,030
+375% +$1.62M 0.05% 403
2020
Q1
$257K Sell
32,808
-76,792
-70% -$1.04M 0.02% 809
2019
Q4
$1.42M Buy
+109,600
New +$1.34M 0.03% 411

Other funds holding TELA

Schonfeld Strategic Advisors's TELA Position: Q4 2024 in Review

Schonfeld Strategic Advisors sold out of TELA Bio (TELA) in Q4 2024, closing a stake of 12,200 shares — an estimated $30.9K sold.

Schonfeld Strategic Advisors first reported a position in TELA in Q4 2019 and held it in 20 quarters. The position peaked at $2.29M in Q1 2023. 47 funds tracked by Wall St. Rank hold TELA as of Q4 2024.

  • Schonfeld Strategic Advisors reported no remaining TELA Bio position as of Q4 2024 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 12,200 TELA Bio shares in Q4 2024, an estimated $30.9K.
  • Schonfeld Strategic Advisors first reported a position in TELA Bio in Q4 2019 and held it in 20 quarters.
  • Schonfeld Strategic Advisors's TELA Bio position peaked at $2.29M in Q1 2023.
  • 47 funds tracked by Wall St. Rank held TELA Bio as of Q4 2024.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.